Green tea catechins are the major constituents of tea leaves and have attracted significant interest in terms of their clinical and curative effects on many diseases. These effects of catechins are due to the radical scavenging and antioxidant activities inherent in polyphenolic compounds. [3] [4] [5] To date, many attempts not only to take advantage of their desirable bioactivities, but also to enhance those activities, have been made. [6] [7] [8] [9] [10] [11] We found that epigallocatechin gallate (EGCG) showed hepatoprotective activity against hepatotoxins, bromobenzene (BB) and rubratoxin B (RB) (to be reported elsewhere). From the viewpoint of the clinical treatment of liver failure, it is important to protect normal hepatocytes from injury by using hepatoprotective agents with high activity and in small doses. Thus, the hepatoprotective effect of EGCG must be enhanced for its clinical use.
Investigation of pharmaceutical activities of metalflavonoid complexes has been attracting interest recently. Satoh et al. reported that the cytotoxic activity of gallic acid for cancer cells was modified by metals. 11) In a study using the oxygen electrode method, Kumamoto et al. found that copper strongly increased the antioxidant activity of EGCG. 6) Thus, the different desirable effects of flavonoids, such as anticancer and antioxidant effects, are found to be enhanced by metals.
In this study, to enhance the hepatoprotective activity of EGCG, the effects of adding metal ions (Fe were examined by using BB as the hepatotoxin. It was found that zinc enhanced the hepatoprotective activity of EGCG. Also, the oxidation potential and the free radical scavenging activity of Zn-EGCG were evaluated using cyclic voltammetry and 1,1-diphenyl-2-picryl-hydrazyl (DPPH) stable radical, respectively. The results are reported herein.
MATERIALS AND METHODS
Chemicals BB was purchased from Wako Pure Chemical Industries (Osaka, Japan). (Ϫ)-Epigallocatechin-3-gallate (EGCG) was isolated from green tea leaf. 12) According to HPLC analysis, the purity of EGCG is higher than 95%. FeSO 4 · 7H 2 O was obtained from Wako Pure Chemical Industries (Osaka, Japan). CuCl 2 · 2H 2 O and ZnCl 2 were from Nacalai Tesque (Kyoto, Japan). DPPH was from Wako Pure Chemical Industries (Osaka, Japan). Other chemicals were obtained from local commercial sources, and used without further purification.
Media The basal medium A consisted of William's E medium (WE, ICN Biochemical, Costa Mesa, CA, U.S.A.), 100 U/ml penicillin G, 100 mg/ml streptomycin, 50 ng/ml amphotericin B, 100 ng/ml aprotinin (Nacalai Tesque, Kyoto, Japan), and 10% (v/v) fetal bovine serum (ICN Biochemicals). Medium B consisted of the medium A supplemented with 1 nM insulin and 1 nM dexamethasone.
Isolation of Hepatocytes Hepatocytes were isolated from male Sprague-Dawley rats weighting 150-200 g by perfusing the liver with collagenase (from Clostridium histolyticum; Sigma-Aldrich, St. Louis, MO, U.S.A.) using the method of Seglen.
13) Hepatocyte preparation with more than 90% viability at the time of isolation was used for the experiments. Cells were seeded at a density of 1ϫ10 5 cells/cm 2 on polystyrene culture plates (Nippon Becton and Dickinson, Tokyo, Japan), and incubated for 6 h in Medium B under the conditions of humidified air with 5% CO 2 at 37°C. After 6 h, Medium B was exchanged for Medium A.
Preparation of Metal-EGCG Complexes
The metal-EGCG complexes were prepared by mixing EGCG with metal salts in water. The formation of the complex was characterized by UV-VIS absorption spectroscopy using a BioSpec-1600 spectrophotometer (Shimadzu, Kyoto, Japan).
Treatment of Cells with Hepatotoxin in the Presence of EGCG and Metals
One day after the isolation of hepatocytes, the medium was replaced with fresh Medium A containing 0.8% (v/v) dimethyl sulfoxide (DMSO) and BB. The final concentration of BB was adjusted to 1 mM. In the experiments investigating the hepatoprotective activities of EGCG, metals and metal-EGCG mixtures, different concentrations of each reagent were added to Medium A. Cells were incubated under each condition for another 24 h, and then the number of viable cells was determined by the trypan blue exclusion assay. Briefly, 0.2% (w/v) trypan blue solution was added to trypsinized cell suspension and viable cells that were not stained were counted. A control run was performed in the medium containing only 0.8% (v/v) DMSO.
Cyclic Voltammetry Cyclic voltammetry was used to observe the redox behaviors of EGCG and metal-EGCG complexes. [14] [15] [16] [17] Cyclic voltammograms were recorded with a 315A potentiostat (Huso Electrochemical System, Kawasaki, Japan), in methanol : 0.1 M phosphate buffer (pH 7.5), (1 : 1, v/v). A glassy carbon (GC) electrode served as the working electrode, an Ag/AgCl electrode was used as the reference electrode, and a platinum electrode was used as a counter electrode. Before each measurement, the GC working electrode was freshly polished with 0.25 mm diamond slurry and rinsed with distilled water. The electrolytic cell was thermostatted at 25.0Ϯ0.1°C.
Antioxidant Determination EGCG and metal-EGCG complex were dissolved in 0.1 M acetate buffer (pH 6.0), and then 1 ml of each solution was added to the same volume of 500 mM DPPH in ethanol (final concentration of 250 mM). The mixture was vortexed and left to stand for 20 min at room temperature in the dark. The absorbance at 517 nm by DPPH was measured using a BioSpec-1600 spectrophotometer (Shimadzu, Kyoto, Japan). 18, 19) Statistics All assays and quantitative measurements were performed in triplicate and the data were analyzed for statistical significance by the Student's t-test.
RESULTS
Protective Effects of EGCG against BB Treatment of the hepatocytes with BB reduced cell viability significantly compared to that of the control run (without BB). To examine the effective concentration for realizing the protective activity of EGCG against BB toxicity, different concentrations of EGCG were added to BB-treated cells. Cell viability was examined by means of the trypan blue exclusion assay and the results are shown in Fig. 1 . EGCG at 0.2 mM significantly (pϽ0.01) protected the cells from BB toxicity. At this condition, viable cell number was kept at inocubated cell number, although in control (-BB), viable cells decreased by cell death associated with monolayer culture. EGCG protected hepatocytes from such cell death associated with cultivation (Fig. 2) . The effect of EGCG (0.2 mM) is considered to be derived from simultaneous protection from both BB and cell death associated with monolayer culture. EGCG at 0.02 mM showed no protective activity against BB toxicity. According to these results, 0.02 mM EGCG was used to examine the effects of metals on the BB toxicity in the subsequent study.
Effects of Metals on the Hepatoprotective Activity of EGCG against BB To elucidate the effects of metal ions (Fe 2ϩ , Cu 2ϩ , Zn 2ϩ ) on the hepatoprotective activity of EGCG, each metal was mixed with EGCG at 0.02 mM. The complex formation with copper was characterized by the shift of the EGCG absorbance to the long-wave length region. In the cases of iron and zinc, the absorbance of EGCG increased and the spectra of both became broader (Fig. 3) . Mixtures of 0.02 mM EGCG and 0.02 mM metal were added to BB-treated cells and the results are shown in Fig. 4 . EGCG at 0.02 mM showed no protective activity against BB toxicity. However, the protective activity was observed by the addition of 0.02 mM EGCG and 0.02 mM zinc. In the case of iron or copper, cell viabilities were almost of the same level as that in the case of EGCG.
To confirm the above effect arised from complex formation between EGCG and metal, protection by metals against BB was examined. Addition of only metals did not protect cells against BB toxicity as shown in Fig. 5 .
Cytotoxic Effects of Metals
The cytotoxic effect of each metal was also examined to confirm the safety of dosing metals to living cells. Each metal at 0.02 mM was added to normal cells and cell viability was measured (Fig. 6) . Of the metals examined, only copper reduced cell viability and exhibited an undesirable cytotoxic effect. Copper is known to produce oxygen radicals and act as a pro-oxidant. The reduced viability of cells is considered to be due to this effect. Iron showed no cytotoxic effect, although it has the ability to produce oxygen radicals. Zinc had no toxic effect and was proven safe for administration.
Optimal Ratio of Zinc to EGCG Then, to determine the optimum ratio of zinc to EGCG for protecting liver cells from BB toxicity, Zn-EGCG complexes were prepared by mixing zinc and EGCG at different ratios and the hepatoprotective activities were examined (Fig. 7) . The hepatoprotective activity of Zn-EGCG was increased with increasing ratio of [ 
Measurement of Radical Scavenging Activity
The radical scavenging activities of EGCG and Zn-EGCG were examined using DPPH. This method is based on the reduction of DPPH, a stable free radical. This reaction has been widely used to test the ability of compounds to act as free radical scavengers or hydrogen donors, and to evaluate the antioxidative activity of food and plant extracts. Figure 9 shows the radical scavenging activity of Zn-EGCG at various ratios of [ZnCl 2 ]/[EGCG], evaluated by the decrease of the absorbance at 517 nm by DPPH. The activity was slightly increased with increasing ratio of zinc. The results suggest that the formation of Zn-EGCG has no marked effect on the radical scavenging activity of EGCG.
DISCUSSION
Zinc is an essential trace element and is capable of protecting against hepatotoxicity produced by a variety of chemicals. Zinc pretreatment had been shown to protect the liver in many mammal models. [20] [21] [22] [23] [24] The mechanism of the zinc-mediated liver protection is related to the increase in hepatic metallothionein concentration. Metallothionein is easily inducible by metal ions and can scavenge reactive oxygen species that cause serious cellular injuries. Zinc acetate was approved by the FDA in 1997 as a drug for Wilson's disease. 25) These facts suggest the safety of zinc supplementation in therapy.
In our previous study, the potential of EGCG to protect hepatocytes from cytotoxin (BB, RB)-induced cell death in cultivation was found (to be published elsewhere). In the present study, we attempted to promote the hepatoprotective activity of EGCG by using metals, with the aim of discovering effective and safe hepatoprotective agents for the treatment of hepatic failure. UV-VIS spectrometry revealed that the absorption of EGCG increased and its peak became large by adding zinc. These results suggested that EGCG complexed with zinc. In the cases of iron and copper, EGCG was also found to complex with them (Fig. 3) . Among the metals examined, zinc was found to significantly enhance the hepatoprotectivity of EGCG (Fig. 4) . Since the addition of only zinc did not protect hepatocytes from BB toxicity, it is supposed that EGCG formed a complex with zinc, thereby becoming more effective in protecting the cells from BB toxicity. The contribution of metallothionein induced by zinc can not be assumed. To our knowledge, this report is the first to show that zinc enhances the hepatoprotective activity of EGCG. Fig. 5 . This suggests that the Zn-EGCG complex may have the structure Zn(EGCG) 2 . Yoshioka et al. proposed the structure of the Cu(II)-epigallocatechin (EGC) complex based on a spin trapping study. According to their model, the ratio of Cu(II) : EGC in the complex was 1 : 2 and the two OH groups at the B-ring of EGC were used for coodination with Cu(II).
26) The corresponding complex structure was proposed for Zn(EGCG) 2 . The transition metals in the complex with a bioflavonoid are thought to acquire additional superoxide dismuting centers and therefore may become more effective free radical scavengers than the parent bioflavonoid.
10) By a similar mechanism, zinc was considered to enhance the radical scavenging activity of EGCG, resulting in the enhancement of the hepatoprotective activity of EGCG against BB toxicity in the form of Zn(EGCG) 2 . In our study, however, the increase in the radical scavenging activity of EGCG by zinc was very small (Fig. 9) . The redox property of Zn-EGCG was similar to that of EGCG (Fig. 8) . Therefore not the physicochemical properties of Zn-EGCG but biological ones are thought to contribute to enhancing the hepatoprotective activity of EGCG. One possible mechanism is that the complexation of EGCG with zinc prevents the inactivation of EGCG by metabolism or auto-oxidation etc., thereby keeping its bioactivity for longer periods.
In conclusion, we demonstrated that the hepatoprotective activity of EGCG was clearly enhanced by zinc and Zn-EGCG could be a potent therapeutic agent for the liver. Our next step is to conduct in vivo studies of Zn-EGCG for clinical use.
